The article you are looking for can not be found in our system.
A follow-up study confirms that random mutations acquired during normal stem cell division likely play a major role in cancer incidence.
With its announced launch of a whole-exome sequencing service for apparently healthy individuals, Ambry Genetics is the latest company to enter this growing market. But whether these services are useful for most people remains up for debate.
The results of a CRISPR-Cas9 study suggest that MELK—a protein thought to play a critical role in cancer—is not necessary for cancer cell survival.